Related Experiment Video
Updated: Oct 10, 2026

TGF-β-mediated Endothelial to Mesenchymal Transition (EndMT) and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
Published on: February 26, 2021
Apoptosis mediators fasL and TRAIL are upregulated in peripheral blood mononuclear cells in MS
Huang W-X1, M P Huang, M A Gomes
1Department of Neurology, Karolinska Institute at Huddinge University Hospital, Sweden. Wen-xin.Huang@neurotec.ki.se
Objective:
To investigate the expression of apoptosis-inducing ligand and receptor molecules in patients with MS.
Background:
Dysregulation of apoptosis may induce autoimmune conditions, possibly through inadequate termination of immune responses, and could be of importance for pathogenesis of MS.
Methods:
Messenger RNA (mRNA) levels of two apoptosis-related members of the tumor necrosis factor (TNF) receptor family, Fas and TNF-related apoptosis-inducing ligand (TRAIL) receptor 2 (TRAIL-R2), and their ligands, Fas ligand (FasL) and TRAIL, were quantified by competitive reverse transcription PCR in unstimulated peripheral blood mononuclear cells in 47 untreated patients with MS and 46 control subjects.
Results:
The expression of FasL was increased in patients with MS compared with healthy control subjects. Analysis of clinical subgroups revealed that the increase was marked in relapsing-remitting MS, being especially high in remission (p = 0.0002), but less so in chronic progressive MS (p = 0.14). Compared with healthy control subjects, TRAIL mRNA levels were also upregulated in patients with MS (p = 0.0001) but did not differ between clinical subgroups. The expression of TRAIL-R2 was slightly elevated in patients with MS (p = 0.02) whereas the expression of Fas was similar in patients and control subjects. The ratio of expression levels for two isoforms of TRAIL-R2, TRICK2a and TRICK2b, in patients with MS differed from healthy control subjects (p = 0.04).
Conclusions:
There was increased expression of both FasL and TRAIL in peripheral blood lymphocytes. It remains to be determined whether this increased expression represents a disease-promoting autoimmune process or is merely the effect of a secondary compensatory mechanism that downregulates the inflammatory response.
Insights
This study found increased expression of Fas ligand (FasL) and TNF-related apoptosis-inducing ligand (TRAIL) in patients with multiple sclerosis (MS). Further research is needed to determine if this impacts the autoimmune process in MS.
Area of Science:
- Immunology
- Neuroscience
- Molecular Biology
Background:
- Dysregulation of apoptosis, a key process in immune cell regulation, is implicated in autoimmune diseases like multiple sclerosis (MS).
- Inadequate apoptosis may lead to the persistence of autoreactive immune cells, contributing to MS pathogenesis.
Purpose of the Study:
- To investigate the expression levels of apoptosis-inducing ligand and receptor molecules in individuals diagnosed with MS.
- To explore the role of apoptosis-related molecules in the context of MS.
Main Methods:
- Quantification of messenger RNA (mRNA) for Fas ligand (FasL), TNF-related apoptosis-inducing ligand (TRAIL), and their receptors (Fas, TRAIL-R2) using competitive reverse transcription PCR.
- Analysis was performed on peripheral blood mononuclear cells from 47 untreated MS patients and 46 healthy controls.
Main Results:
- Significantly increased expression of FasL mRNA was observed in MS patients, particularly in the relapsing-remitting MS subgroup during remission.
- TRAIL mRNA levels were also upregulated in MS patients compared to controls, with no significant differences between clinical subgroups.
- TRAIL-R2 expression was slightly elevated in MS patients, while Fas expression remained similar between groups. Differences in TRAIL-R2 isoforms (TRICK2a/TRICK2b) were noted in MS patients.
Conclusions:
- Peripheral blood lymphocytes in MS patients exhibit elevated expression of FasL and TRAIL.
- The clinical significance of this increased expression requires further investigation to ascertain if it promotes autoimmunity or acts as a compensatory anti-inflammatory mechanism.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Apoptosis